The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) EV-to-EBITDA: (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:IBNSINA The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
21 GF Score
Price BDT322.40
View Full Analysis

What is The IBN SINA Pharmaceutical Industry EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, The IBN SINA Pharmaceutical Industry's enterprise value is BDT0.00 Mil. The IBN SINA Pharmaceutical Industry does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate The IBN SINA Pharmaceutical Industry's EV-to-EBITDA at this moment.

The historical rank and industry rank for The IBN SINA Pharmaceutical Industry's EV-to-EBITDA or its related term are showing as below:

DHA:IBNSINA's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 13.3
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-08-14), The IBN SINA Pharmaceutical Industry's stock price is BDT322.40. The IBN SINA Pharmaceutical Industry does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate The IBN SINA Pharmaceutical Industry's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

The IBN SINA Pharmaceutical Industry  (DHA:IBNSINA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

The IBN SINA Pharmaceutical Industry's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=322.40/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

The IBN SINA Pharmaceutical Industry EV-to-EBITDA Related Terms

The IBN SINA Pharmaceutical Industry EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for The IBN SINA Pharmaceutical Industry's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The IBN SINA Pharmaceutical Industry EV-to-EBITDA Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
EV-to-EBITDA

The IBN SINA Pharmaceutical Industry Semi-Annual Data
EV-to-EBITDA

DHA:IBNSINA vs IMNPQ: EV-to-EBITDA Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, The IBN SINA Pharmaceutical Industry's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The IBN SINA Pharmaceutical Industry EV-to-EBITDA vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The IBN SINA Pharmaceutical Industry's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where The IBN SINA Pharmaceutical Industry's EV-to-EBITDA falls into.


DHA:IBNSINA
21GF Score
The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The IBN SINA Pharmaceutical Industry EV-to-EBITDA Calculation

The IBN SINA Pharmaceutical Industry's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/
=

The IBN SINA Pharmaceutical Industry Business Description

Address Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
21GF Score

Get the complete analysis for DHA:IBNSINA

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT322.40
Price